# BAYER PHARMA, AG - Inspection Records

Source: https://www.keypedia.com/companies/bayer-pharma-ag/28300a22-c506-4b1a-9052-6fc4e7170384

> Inspection records and compliance data for BAYER PHARMA, AG in Berlin, None. Access full analysis and detailed observations.

---

## Details

- Name: BAYER PHARMA, AG
- FEI Number: 3002808086
- City: Berlin
- State: None
- Country Name: Germany
- Address Line 1: Mullerstr. 170-178
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1282736 - BAYER PHARMA, AG - 2024-06-06](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/1d238dca-b4e7-4c8f-8c8c-40de3cf1da86) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2024
- [FDA Inspection 1239178 - BAYER PHARMA, AG - 2021-08-27](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/45945a5c-5b62-45e5-93ff-085140511f3a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 27, 2021
- [FDA Inspection 1102816 - BAYER PHARMA, AG - 2019-09-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/f4d6e717-a64d-42ca-931d-40fe4ad01598) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2019
- [FDA Inspection 1001127 - BAYER PHARMA, AG - 2017-01-24](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/5e47f2e1-951b-482a-ad43-bb89fe81b130) — classification: No Action Indicated (NAI), source: FDA, date: January 24, 2017
- [FDA Inspection 889209 - BAYER PHARMA, AG - 2014-05-13](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/62dcd89d-3755-4ff0-bfd0-1cd68e1ec209) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 13, 2014
- [FDA Inspection 876478 - BAYER PHARMA, AG - 2014-04-17](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/1e6d1354-7051-4717-a4b2-9c5793d18b21) — classification: No Action Indicated (NAI), source: FDA, date: April 17, 2014
- [FDA Inspection 803657 - BAYER PHARMA, AG - 2012-09-18](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/b86e49f0-3e12-47bb-bb4d-b311054042e7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2012
- [FDA Inspection 716641 - BAYER PHARMA, AG - 2010-11-19](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/aaaec219-d433-414f-82d1-8aa66d4c3e2f) — classification: No Action Indicated (NAI), source: FDA, date: November 19, 2010
- [FDA Inspection 704427 - BAYER PHARMA, AG - 2010-11-16](https://www.keypedia.com/records/fda_inspections/bayer-pharma-ag/c4b89ccb-9a92-40ef-8250-d29e4703d788) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2010

## Related Companies

- [N.V. Organon (MSD)](https://www.keypedia.com/companies/nv-organon-msd/dc305126-e2d1-4dba-8538-f815391f40a5)
- [Fresenius Kabi iPSUM Srl](https://www.keypedia.com/companies/fresenius-kabi-ipsum-srl/57155542-2a5d-4530-8d4e-f08876ccf2d5)
- [Aspen Notre Dame de Bondeville](https://www.keypedia.com/companies/aspen-notre-dame-de-bondeville/194f72ec-2218-470f-bdd4-76cfcd04064d)
- [Organon Heist](https://www.keypedia.com/companies/organon-heist/e737764b-560f-483a-be05-cec3a613c7fb)
- [Baxter Healthcare S.A.](https://www.keypedia.com/companies/baxter-healthcare-sa/027068ec-1edf-444c-aabb-c9da8dbf31f0)
- [Baxter, S.A. De C.V.](https://www.keypedia.com/companies/baxter-sa-de-cv/f8b22a08-81dc-42b5-a63e-55b31afb5428)
- [Zhejiang Yongning Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-yongning-pharmaceutical-co-ltd/70a5bf94-4ed4-42f8-9efe-e4917c7aae66)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)](https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-jinqiao-road-site/78556cbd-f0c8-40a5-a1f2-3ab0dce403ee)
- [ONY Biotech, Inc.](https://www.keypedia.com/companies/ony-biotech-inc/a2997e30-1b39-4dea-9fec-a960aafcefd0)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/19a30564-2115-4586-a055-e1b5efcf06ee)